Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18550415 | 0.95 | ALDH1A1 (0.35) | ALDH1A1TSHRGABRA1GABRB2 | |
| SCHEMBL1048140 | 0.91 | ALDH1A1 (0.33) | ALDH1A1TSHRGABRA1GABRB2 | |
| SCHEMBL338177 | 0.87 | GABRA1 (0.38) | ALDH1A1TSHRGABRA1GABRB2 | |
| SCHEMBL1049876 | 0.85 | — | — | |
| SCHEMBL15653446 | 0.82 | TAAR1 (0.40) | ALDH1A1 | |
| SCHEMBL1048345 | 0.81 | — | — | |
| SCHEMBL1050929 | 0.80 | L3MBTL1 (0.30) | — | |
| SCHEMBL15652995 | 0.77 | TAAR1 (0.40) | — | |
| SCHEMBL1049731 | 0.77 | TSHR (0.41) | ALDH1A1TSHR | |
| SCHEMBL234202 | 0.76 | TSHR (0.39) | ALDH1A1TSHRGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7863239-B2 | polypeptide which is cysteine-knot growth factor family member attached to scaffold such as bis(bromomethyl)benzene; point mutations; treating infection and autoimmune disorders | PEPSCAN SYSTEMS B.V. (NL) | 2011-01-04 | — | — | US | disclosed |
| US-20080313749-A1 | Binding Compounds, Immunogenic Compounds and Peptidomimetics | PEPSCAN SYSTEMS B.V. (NL) | 2008-12-18 | — | — | US | disclosed |
| EP-1844337-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2007-10-17 | — | — | EP | disclosed |
| WO-2006078161-A1 | BINDING COMPOUNDS, IMMUNOGENIC COMPOUNDS AND PEPTIDOMIMETICS | PEPSCAN SYSTEMS B.V. (NL) | 2006-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080313749-A1 | Binding Compounds, Immunogenic Compounds and Peptidomimetics | CXCL10, CCL2, CD74 | ALDH1A1 4812/4885TSHR 3066/4885GABRA1 2583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.